News

In the past two weeks, U.S. public health authorities have skirted normal procedures and announced two major policy changes ...
We want to know more about what these products are doing,” said Dr. Vinay Prasad during a recent FDA livestreamed ...
Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the ...
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
The Food and Drug Administration on Tuesday named Dr. Vinay Prasad — a hematologist-oncologist who has been accused of spreading misinformation about Covid vaccines and was an outspoken critic ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of ... of medicines for gravely ill patients. During the COVID-19 pandemic, Prasad reached a much broader audience as a critic of vaccine ...
After the FDA announced that it would no longer authorize new COVID-19 vaccines for healthy Americans under age 65, the CDC ...
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s ...